Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Boban

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Dementia and Geriatric Cognitive Disorders|July 21, 2012
The reliability and validity of the mini-mental state examination in the elderly Croatian populationMarina Boban, Branko Malojčić, Ninoslav Mimica, et al.
Psychiatria Danubina|June 23, 2018
Significantly lower right middle cerebral artery blood flow velocity in the first episode of psychosis during neurocognitive testingIvana Kekin, Dina Bosnjak, Porin Makaric, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 16, 2010
Systemic thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: first Croatian experiencesVesna Matijević, Domagoj Alvir, Branko Malojčić, et al.
Collegium Antropologicum|April 15, 2008
Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementiaMarina Boban, Kristina Grbić, Mihovil Mladinov, et al.
Neurology International|July 25, 2023
Soluble TREM2 Concentrations in the Cerebrospinal Fluid Correlate with the Severity of Neurofibrillary Degeneration, Cognitive Impairment, and Inflammasome Activation in Alzheimer's DiseaseEna Španić Popovački, Mirjana Babić Leko, Lea Langer Horvat, et al.
Journal of the Neurological Sciences|November 9, 2011
Systemic thrombolytic therapy in acute ischemic stroke--new experiences in spreading network of stroke units in CroatiaVesna Matijević, Zdravka Poljaković, Branko Malojčić, et al.
CNS Neuroscience & Therapeutics|February 18, 2018
Evaluation of cerebrospinal fluid phosphorylated tau<sub>231</sub> as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementiaSpomenka Kiđemet-Piskač, Mirjana Babić Leko, Antonela Blažeković, et al.
Frontiers in Molecular Neuroscience|October 10, 2024
Further validation of the association between <i>MAPT</i> haplotype-tagging polymorphisms and Alzheimer's disease: neuropsychological tests, cerebrospinal fluid biomarkers, and <i>APOE</i> genotypeMirjana Babić Leko, Ena Španić Popovački, Nanet Willumsen, et al.
BMC Medicine|February 10, 2017
Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's diseaseBranko Malojcic, Panteleimon Giannakopoulos, Farzaneh A Sorond, et al.
Neuropsychiatric Disease and Treatment|September 12, 2019
Dementia care in the Danube Region. A multi-national expert surveyShima Mehrabian, Larissa Schwarzkopf, Stefanie Auer, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Dementia and Geriatric Cognitive Disorders|July 21, 2012
The reliability and validity of the mini-mental state examination in the elderly Croatian populationMarina Boban, Branko Malojčić, Ninoslav Mimica, et al.
Psychiatria Danubina|June 23, 2018
Significantly lower right middle cerebral artery blood flow velocity in the first episode of psychosis during neurocognitive testingIvana Kekin, Dina Bosnjak, Porin Makaric, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 16, 2010
Systemic thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: first Croatian experiencesVesna Matijević, Domagoj Alvir, Branko Malojčić, et al.
Collegium Antropologicum|April 15, 2008
Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementiaMarina Boban, Kristina Grbić, Mihovil Mladinov, et al.
Neurology International|July 25, 2023
Soluble TREM2 Concentrations in the Cerebrospinal Fluid Correlate with the Severity of Neurofibrillary Degeneration, Cognitive Impairment, and Inflammasome Activation in Alzheimer's DiseaseEna Španić Popovački, Mirjana Babić Leko, Lea Langer Horvat, et al.
Journal of the Neurological Sciences|November 9, 2011
Systemic thrombolytic therapy in acute ischemic stroke--new experiences in spreading network of stroke units in CroatiaVesna Matijević, Zdravka Poljaković, Branko Malojčić, et al.
CNS Neuroscience & Therapeutics|February 18, 2018
Evaluation of cerebrospinal fluid phosphorylated tau<sub>231</sub> as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementiaSpomenka Kiđemet-Piskač, Mirjana Babić Leko, Antonela Blažeković, et al.
Frontiers in Molecular Neuroscience|October 10, 2024
Further validation of the association between <i>MAPT</i> haplotype-tagging polymorphisms and Alzheimer's disease: neuropsychological tests, cerebrospinal fluid biomarkers, and <i>APOE</i> genotypeMirjana Babić Leko, Ena Španić Popovački, Nanet Willumsen, et al.
BMC Medicine|February 10, 2017
Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's diseaseBranko Malojcic, Panteleimon Giannakopoulos, Farzaneh A Sorond, et al.
Neuropsychiatric Disease and Treatment|September 12, 2019
Dementia care in the Danube Region. A multi-national expert surveyShima Mehrabian, Larissa Schwarzkopf, Stefanie Auer, et al.
Pageof 3